These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 37793170)
1. Hepatitis C Treatment in People With HIV: Potential to Eliminate Disease and Disparity. Falade-Nwulia O; Lesko CR; Fojo AT; Keruly JC; Moore RD; Sutcliffe CG; Mehta SH; Chander G; Thomas DL; Sulkowski M J Infect Dis; 2024 Mar; 229(3):775-779. PubMed ID: 37793170 [TBL] [Abstract][Full Text] [Related]
2. Low hepatitis C virus-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the Netherlands. Isfordink CJ; Smit C; Boyd A; de Regt MJA; Rijnders BJA; van Crevel R; Ackens RP; Reiss P; Arends JE; van der Valk M; AIDS; 2022 May; 36(6):773-783. PubMed ID: 34999607 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis C microelimination among people living with HIV in Taiwan. Chen GJ; Ho SY; Su LH; Chang SY; Hsieh SM; Sheng WH; Liu WD; Huang YS; Lin KY; Chen YT; Su YC; Liu WC; Sun HY; Hung CC Emerg Microbes Infect; 2022 Dec; 11(1):1664-1671. PubMed ID: 35608049 [TBL] [Abstract][Full Text] [Related]
4. Alcohol consumption upon direct-acting antiviral therapy for hepatitis C among persons with human immunodeficiency virus in the United States. Chen PH; Yenokyan K; Fojo AT; Hutton HE; Lesko CR; McCaul ME; Yang C; Cachay ER; Crane HM; Jacobson JM; Kim HN; Kitahata MM; Mayer KH; Moore RD; Napravnik S; Saag M; Lau B; Chander G Drug Alcohol Depend; 2022 Dec; 241():109673. PubMed ID: 36332596 [TBL] [Abstract][Full Text] [Related]
5. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan. Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032 [TBL] [Abstract][Full Text] [Related]
6. Mortality in hepatitis C virus-cured vs. hepatitis C virus-uninfected people with HIV. Requena MB; Grabar S; Lanoy E; Pialoux G; Billaud E; Duvivier C; Merle P; Piroth L; Tattevin P; Salmon D; Weiss L; Costagliola D; Lacombe K AIDS; 2023 Jul; 37(8):1297-1306. PubMed ID: 37070541 [TBL] [Abstract][Full Text] [Related]
7. Progress of Hepatitis C elimination in Viennese people living with HIV after two decades of increasing cure rates. Chromy D; Bauer D; Simbrunner B; Jachs M; Hartl L; Schwabl P; Binter T; Steininger L; Schwarz C; Rieger A; Grabmeier-Pfistershammer K; Trauner M; Ferenci P; Peck-Radosavljevic M; Mandorfer M; Reiberger T Infect Dis (Lond); 2023 Mar; 55(3):189-198. PubMed ID: 36484317 [TBL] [Abstract][Full Text] [Related]
8. Temporal trends in HCV treatment uptake and success among people who inject drugs in Baltimore, MD since the introduction of direct acting antivirals. Coyle CR; Gicquelais RE; Genberg BL; Astemborski J; Falade-Nwulia O; Kirk GD; Thomas DL; Mehta SH Drug Alcohol Depend; 2023 Dec; 253():. PubMed ID: 38456165 [TBL] [Abstract][Full Text] [Related]
9. Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada. Kronfli N; Nitulescu R; Cox J; Moodie EE; Wong A; Cooper C; Gill J; Walmsley S; Martel-Laferrière V; Hull MW; Klein MB; J Int AIDS Soc; 2018 Nov; 21(11):e25197. PubMed ID: 30460791 [TBL] [Abstract][Full Text] [Related]
10. Human pegivirus viremia in HCV/HIV co-infected patients: Direct acting antivirals exert anti-pegivirus effects. Hlavay BA; Zhuo R; Ogando N; Charlton C; Stapleton JT; Klein MB; Power C J Clin Virol; 2023 May; 162():105445. PubMed ID: 37043902 [TBL] [Abstract][Full Text] [Related]
11. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies. Sacks-Davis R; van Santen DK; Boyd A; Young J; Stewart A; Doyle JS; Rauch A; Mugglin C; Klein M; van der Valk M; Smit C; Jarrin I; Berenguer J; Lacombe K; Requena MB; Wittkop L; Leleux O; Bonnet F; Salmon D; Matthews GV; Guy R; Martin NK; Spelman T; Prins M; Stoove M; Hellard M; Lancet HIV; 2024 Feb; 11(2):e106-e116. PubMed ID: 38224708 [TBL] [Abstract][Full Text] [Related]
12. The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national elimination. Young J; Wang S; Lanièce Delaunay C; Cooper CL; Cox J; Gill MJ; Hull M; Walmsley S; Wong A; Klein MB; Int J Drug Policy; 2023 Apr; 114():103981. PubMed ID: 36893502 [TBL] [Abstract][Full Text] [Related]
13. The 'Viennese epidemic' of acute HCV in the era of direct-acting antivirals. Chromy D; Bauer DJM; Simbrunner B; Jachs M; Hartl L; Schwabl P; Schwarz C; Rieger A; Grabmeier-Pfistershammer K; Trauner M; Ferenci P; Mandorfer M; Gschwantler M; Reiberger T J Viral Hepat; 2022 May; 29(5):385-394. PubMed ID: 35274399 [TBL] [Abstract][Full Text] [Related]
14. Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada. Saeed S; Strumpf EC; Moodie EE; Young J; Nitulescu R; Cox J; Wong A; Walmsely S; Cooper C; Vachon ML; Martel-Laferriere V; Hull M; Conway B; Klein MB; J Int AIDS Soc; 2017 Nov; 20(3):. PubMed ID: 29116684 [TBL] [Abstract][Full Text] [Related]
15. Improvements in liver transplant outcomes in patients with HCV/HIV coinfection after the introduction of direct-acting antiviral therapies. Shimada S; Ivanics T; Kitajima T; Shamaa T; Rizzari M; Collins K; Yoshida A; Abouljoud M; Moonka D; Zhang J; Lu M; Nagai S Transpl Infect Dis; 2022 Apr; 24(2):e13808. PubMed ID: 35157334 [TBL] [Abstract][Full Text] [Related]
16. Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study. Isfordink CJ; Boyd A; Sacks-Davis R; van Santen DK; Smit C; Martinello M; Stoove M; Berenguer J; Wittkop L; Klein MB; Rauch A; Salmon D; Lacombe K; Stewart A; Schinkel J; Doyle JS; Hellard M; van der Valk M; Matthews GV; Lancet Public Health; 2023 Apr; 8(4):e294-e304. PubMed ID: 36965984 [TBL] [Abstract][Full Text] [Related]
17. Decline in Hepatitis C Virus (HCV) Incidence in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Progress to HCV Microelimination in the United Kingdom? Garvey LJ; Cooke GS; Smith C; Stingone C; Ghosh I; Dakshina S; Jain L; Waters LJ; Mahungu T; Ferro F; Sood C; Freeman C; Phillips C; Dhairyawan R; Burholt R; Sharp H; Ullah S; Gilleece Y; Brown A; Orkin C; Rodger A; Bhagani S Clin Infect Dis; 2021 Jan; 72(2):233-238. PubMed ID: 32211763 [TBL] [Abstract][Full Text] [Related]
18. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada. Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB; Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989 [TBL] [Abstract][Full Text] [Related]
19. Perceptions Towards HCV Treatment with Direct Acting Antivirals (DAAs): A Qualitative Analysis with Persons with HIV/HCV Co-infection Who Delay or Refuse Treatment. Brothers S; DiDomizio E; Nichols L; Brooks R; Villanueva M AIDS Behav; 2023 Jan; 27(1):119-133. PubMed ID: 35776253 [TBL] [Abstract][Full Text] [Related]
20. Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada. Marathe G; Moodie EEM; Brouillette MJ; Lanièce Delaunay C; Cox J; Martel-Laferrière V; Gill J; Cooper C; Pick N; Vachon ML; Walmsley S; Klein MB; Clin Infect Dis; 2023 Feb; 76(3):e702-e709. PubMed ID: 35789253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]